Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
CMOs showed an increasing reluctance to take on debt in 2022
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
This artificial RNA ligase has higher thermostability than natural RNA ligase
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Allam was serving recently as the CEO at Public Investment Fund
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
The need is to vaccinate people who have not contracted Covid-19
Subscribe To Our Newsletter & Stay Updated